Intranasal Bevacizumab for HHT-Related Epistaxis
A Prospective Randomised Controlled Trial of Management of Recurrent Nosebleeds in Children
|3||Not yet recruiting||
Prospective Pilot Study of Floseal for the Treatment of Anterior Epistaxis in Patients With (HHT)
|4||Not yet recruiting||
Management of Persistent Epistaxis Using Floseal Hemostatic Matrix
, "Mucosal Injury During Nasotracheal Intubation for Dental Procedures in Children-does the Tube Design Matter?"
Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
The Effect of Intranasal Vasoconstrictor Medications on Hemodynamic Parameters: A Randomized Double-blind, Placebo-controlled Trial.
Double Versus Single Pledget Nasal Anesthesia for Transnasal Endoscopy
A Novel Anterior Rhinoscopic Scoring Scale to Predict Nasal Insertability Before Transnasal Endoscopy
Topical Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
Efficacy of a Timolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) - Randomized Trial Versus Placebo
Treatment of Hereditary Hemorrhagic Telangiectasia of the Nasal Mucosa by Intranasal Bevacizumab : Search for Effective Dose
Iron Deficiency and Hereditary Haemorrhagic Telangiectasia
† Indicates status has not been verified in more than two years